FRESENIUS SE+CO.KGAA O.N.

- EUR (-)

- 15 min delayed data - Germany Stocks

Open:	-
Change:	-
Volume:	-

Low:	-
High:	-
High / Low range:	-

Type:	Stocks
Ticker:	FRE
ISIN:	DE0005785604

FRESENIUS SE+CO.KGAA O.N. overview

> News EQS Group published a news.

EQS-AGM: Fresenius SE & Co. KGaA: Announcement of the Convening of the General Meeting in Frankfurt am Main on 17.05.2024 according to article 121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution • • EQS Group • Stocks • More FRESENIUS SE+CO.KGAA O.N. news...

EQS-News: Fresenius SE & Co. KGaA / Announcement of the Convening of the General Meeting Fresenius SE & Co. KGaA: Announcement of the Convening of the General Meeting in Frankfurt am Main on 17.05.2024 according to article 121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution 02.04.2024 / 15:06 CET/CEST Announcement according to article 121 AktG (German Stock Companies Act), transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for...

Thank you Chart

> Analyses

Londinia AI has published a new analysis.

0
72061
15096
0

FRESENIUS SE+CO.KGAA O.N. - Daily

Timeframe : Daily - Simple chart
Status : LEVEL MAINTAINED

All elements being clearly bearish, it would be possible for traders to trade only short positions (for sale) on FRESENIUS SE+CO.KGAA O.N. as long as the price remains well below 26.45 EUR. The…

Thank you Reply Chart

> News EQS Group published a news.

EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius retains relief payments for hospitals of up to €300 million (from the current perspective) and is therefore subject to a ban on dividends and bonuses for 2023 • • EQS Group • Stocks • More FRESENIUS SE+CO.KGAA O.N. news...

EQS-Ad-hoc: Fresenius SE & Co. KGaA / Key word(s): Dividend Fresenius SE & Co. KGaA: Fresenius retains relief payments for hospitals of up to €300 million (from the current perspective) and is therefore subject to a ban on dividends and bonuses for 2023 05-Dec-2023 / 21:29 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this...

Thank you Chart

> News ACCESSWIRE published a news.

Prometheus Laboratories Announces Collaboration with Fresenius Kabi on Anser Testing • • ACCESSWIRE • Stocks • More FRESENIUS SE+CO.KGAA O.N. news...

SAN DIEGO, CA / ACCESSWIRE / August 1, 2023 / Prometheus Laboratories Inc. ("Prometheus") today announced a collaboration with Fresenius Kabi to support the validation of and access to Anser ® therapeutic drug monitoring (TDM) services for eligible patients receiving the Fresenius Kabi biosimilar, IDACIO ® (adalimumab-aacf). Anser testing is utilized by clinicians treating immune-mediated diseases such as Inflammatory Bowel Disease (IBD) and Rheumatoid Arthritis (RA) to gain objective...

Thank you Chart

> News EQS Group published a news.

EQS-AGM: Fresenius SE & Co. KGaA: Announcement of the Convening of the General Meeting in Frankfurt am Main on 17.05.2023 according to article 121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution • • EQS Group • Stocks • More FRESENIUS SE+CO.KGAA O.N. news...

EQS-News: Fresenius SE & Co. KGaA / Announcement of the Convening of the General Meeting Fresenius SE & Co. KGaA: Announcement of the Convening of the General Meeting in Frankfurt am Main on 17.05.2023 according to article 121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution 30.03.2023 / 15:13 CET/CEST Announcement according to article 121 AktG (German Stock Companies Act), transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for...

Thank you Chart

> Analyses

Londinia AI has published a new analysis.

0
72061
15096
0

FRESENIUS SE+CO.KGAA O.N. - Daily

Timeframe : Daily - Simple chart
Status : INVALID

All elements being clearly bearish, it would be possible for traders to trade only short positions (for sale) on FRESENIUS SE+CO.KGAA O.N. as long as the price remains well below 24.08 EUR. The…

Thank you Reply Chart

> News EQS Group published a news.

EQS-Adhoc: Fresenius SE & Co. KGaA: Outlook 2023 – Fresenius advances with deconsolidation of Fresenius Medical Care by changing its legal form into a German stock corporation (Aktiengesellschaft) • • EQS Group • Stocks • More FRESENIUS SE+CO.KGAA O.N. news...

EQS-Ad-hoc: Fresenius SE & Co. KGaA / Key word(s): Forecast/Strategic Company Decision Fresenius SE & Co. KGaA: Outlook 2023 – Fresenius advances with deconsolidation of Fresenius Medical Care by changing its legal form into a German stock corporation (Aktiengesellschaft) 21-Feb-2023 / 19:02 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content...

Thank you Chart

> News EQS Group published a news.

EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius SE & Co. KGaA confirms review of deconsolidation of Fresenius Medical Care through change of legal form into a stock corporation • • EQS Group • Stocks • More FRESENIUS SE+CO.KGAA O.N. news...

EQS-Ad-hoc: Fresenius SE & Co. KGaA / Key word(s): Miscellaneous Fresenius SE & Co. KGaA: Fresenius SE & Co. KGaA confirms review of deconsolidation of Fresenius Medical Care through change of legal form into a stock corporation 09-Feb-2023 / 16:24 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. As part of the...

Thank you Chart

Load more content